» Articles » PMID: 15188028

The Pattern of Cytokine Gene Expression in Human Colorectal Carcinoma

Overview
Specialty Oncology
Date 2004 Jun 10
PMID 15188028
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic and local cytokine environment may modulate the immunogenicity of colorectal cancer cells, and affect anti-tumor immune functions of tumor-infiltrating lymphocytes. We therefore investigated cytokine mRNA expression patterns in tumors and peripheral blood mononuclear cells (PBMC) from patients with colorectal adenocarcinoma. IL-2, IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-4, IL-6, IL-8, IL-10 and IL-1 beta mRNAs in single cell suspension of freshly isolated colorectal cancer tissue were studied by RT-PCR. Frequencies of cytokine gene expression were compared to those in normal colonic mucosa from tumor patients. The frequencies of IL-2, IFN-gamma, IL-4 and IL-10 gene expression were also determined in peripheral blood mononuclear cells from patients with colorectal adenocarcinoma and compared to those of healthy individuals. Tumor samples were more frequently positive for IFN-gamma, IL-2, TNF-alpha and IL-10 gene expression than normal mucosa (p=0.0001, p=0.0118, p=0.001 and p<0.0001, respectively). Frequencies of IL-2 and TNF-alpha gene expressions were significantly higher in tumors with a diameter <5 cm, than in those with a diameter >5 cm. The genes for IL-6, IL-1 beta and IL-8 were commonly expressed in both tumor tissue and normal colonic mucosa. IFN-gamma transcripts were detected in more PBMC samples from patients with colorectal cancer than those from normal controls (p=0.0449). Thus, colorectal cancer tissue is characterized by a specific pattern of cytokine gene expression. It is likely that multiple interactions between pro- and anti-inflammatory cytokines regulate tumor growth and the functional activity of tumor-infiltrating lymphocytes.

Citing Articles

In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells.

Serwaa A, Oyawoye F, Owusu I, Dosoo D, Manu A, Sobo A Sci Rep. 2024; 14(1):24625.

PMID: 39427065 PMC: 11490510. DOI: 10.1038/s41598-024-75718-1.


Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.

Lau L, Mohammed N, Dimitroff C Int J Mol Sci. 2022; 23(24).

PMID: 36555198 PMC: 9778980. DOI: 10.3390/ijms232415554.


Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.

Bhat A, Nisar S, Singh M, Ashraf B, Masoodi T, Prasad C Cancer Commun (Lond). 2022; 42(8):689-715.

PMID: 35791509 PMC: 9395317. DOI: 10.1002/cac2.12295.


Is the nuclear factor kappa-b (NF-κB) pathway and inflammatory status associated with colorectal cancer?.

Atabilen B, Akbulut G, Bacanli M, Uncu D Saudi J Gastroenterol. 2021; 28(1):60-66.

PMID: 34380870 PMC: 8919927. DOI: 10.4103/sjg.sjg_44_21.


Initiation of Pancreatic Cancer: The Interplay of Hyperglycemia and Macrophages Promotes the Acquisition of Malignancy-Associated Properties in Pancreatic Ductal Epithelial Cells.

Otto L, Rahn S, Daunke T, Walter F, Winter E, Moller J Int J Mol Sci. 2021; 22(10).

PMID: 34064969 PMC: 8151031. DOI: 10.3390/ijms22105086.


References
1.
Ono M, Torisu H, Fukushi J, Nishie A, Kuwano M . Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother Pharmacol. 1999; 43 Suppl:S69-71. DOI: 10.1007/s002800051101. View

2.
De Vita F, Orditura M, Galizia G, Romano C, Infusino S, Auriemma A . Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer. 1999; 86(10):1936-43. View

3.
Melichar B, Touskova M, Vesely P . Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer. Hepatogastroenterology. 2002; 49(46):967-70. View

4.
Hilgenfeld R, Kreuser E . Immunological and biochemical modulation in the treatment of advanced colorectal cancer: update and future directions. Curr Top Microbiol Immunol. 1996; 213 ( Pt 3):217-40. DOI: 10.1007/978-3-642-80071-9_13. View

5.
Coca S, Martinez D, Colmenarejo A, Saez M, Vallejo C, Martos J . The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer. 1997; 79(12):2320-8. DOI: 10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p. View